Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Molecular Pharmacology

• Publication date

  2018-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1124/mol.117.111468PMID 29674523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity

  2017influential reference
• High-Throughput Screens to Discover Small-Molecule Modulators of Ryanodine Receptor Calcium Release Channels

  2017cited by this paper
• Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy

  2017cited by this paper
• Genotype–Phenotype Correlations of Malignant Hyperthermia and Central Core Disease Mutations in the Central Region of the RYR1 Channel

  2016influential reference
• Divergent Activity Profiles of Type 1 Ryanodine Receptor Channels Carrying Malignant Hyperthermia and Central Core Disease Mutations in the Amino-Terminal Region

  2015influential reference
• Imaging intraorganellar Ca2+ at subcellular resolution using CEPIA

  2014influential reference
• Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.

  2011cited by this paper
• Three independent mechanisms contribute to tetracaine inhibition of cardiac calcium release channels.

  2011cited by this paper
• Carvedilol and its new analogs suppress arrhythmogenic store overload–induced Ca2+ release

  2011cited by this paper
• Ryanodine receptor channelopathies

  2010cited by this paper
• Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1

  2010cited by this paper
• A practical guide to the preparation of Ca(2+) buffers.

  2010cited by this paper
• Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

  2009cited by this paper
• Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.

  2008cited by this paper
• Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.

  2008cited by this paper
• A role of the 9-aminoacridines and their conjugates in a life science.

  2007cited by this paper
• Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent

  2006cited by this paper
• Mutations in RYR1 in malignant hyperthermia and central core disease

  2006cited by this paper
• Macromolecular complexes regulating cardiac ryanodine receptor function.

  2004cited by this paper
• Electrostatic mechanisms underlie neomycin block of the cardiac ryanodine receptor channel (RyR2).

  2004cited by this paper
• Ryanodine receptor calcium release channels.

  2002cited by this paper
• Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor.

  1998cited by this paper
• Role of ryanodine receptors.

  1994cited by this paper
• Ryanodine receptor/Ca2+ release channels and their regulation by endogenous effectors.

  1994cited by this paper
• A practical guide to the preparation of Ca2+ buffers.

  1994cited by this paper
• Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle

  1993cited by this paper
• Temperature-dependent in vitro antimicrobial activity of four 4-quinolones and oxytetracycline against bacteria pathogenic to fish

  1992cited by this paper
• Involvement of sarcoplasmic reticulum ‘Ca2+ release channels’ in excitation‐contraction coupling in vertebrate skeletal muscle.

  1992cited by this paper
• Calcium chelation induced glutathione efflux from tumor cells and prevention by ruthenium red or neomycin.

  1991cited by this paper
• Drug-induced Ca2+ release from isolated sarcoplasmic reticulum. II. Releases involving a Ca2+-induced Ca2+ release channel.

  1987cited by this paper
• Dantrolene in Human Malignant Hyperthermia A Multicenter Study

  1982cited by this paper
• Dantrolene in human malignant hyperthermia.

  1982cited by this paper
• NEUROMUSCULAR AND HEMODYNAMIC EFFECTS OF ATRACURIUM DURING ENFLURANE ANESTHESIA

  1982cited by this paper
• Drug therapy reviews: oxolinic acid.

  1979cited by this paper
• Cholesterol modulates activity of calcium-dependent ATPase of the sarcoplasmic reticulum

  1979cited by this paper
• In vitro antiplaque properties of a series of alkyl bis(biguanides).

  1978cited by this paper
• The mechanism of action of inhibitors of DNA synthesis.

  1977cited by this paper
• Phospholipid orientation in sarcoplasmic membranes: spin-label ESR and proton MNR studies.

  1972cited by this paper

• Cryo-EM Brings the Mechanisms of Activation, Inactivation, and Inhibition of Ryanodine Receptors into Focus.

  2026cites this paper
• Development of selective RyR2 inhibitors with a pharmacophore containing a parabanic acid skeleton.

  2025cites this paper
• Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeutics

  2025cites this paper
• Crystal structures of Ryanodine Receptor reveal dantrolene and azumolene interactions guiding inhibitor development

  2025cites this paper
• Two journeys, one diagnosis: exploring the clinical outcomes of twins with congenital myopathy

  2025cites this paper
• Multitargeted Caffeic Acid Derivatives Inhibit Cardiac RyR2- and NaV1.5- Channels but Stimulate SERCA2a Pump Activity

  2025cites this paper
• Using Fluorescent GAP Indicators to Monitor ER Ca2+

  2024cites this paper
• Melatonin Ameliorates Organellar Calcium Homeostasis, Improving Endoplasmic Reticulum Stress-Mediated Apoptosis in the Vastus Lateralis Muscle of Both Sexes of Obese Diabetic Rats

  2024cites this paper
• Dantrolene inhibition of ryanodine receptor 1 carrying the severe malignant hyperthermia mutation Y522S visualized by cryo-EM

  2024influential citation
• Cryo-EM structures of ryanodine receptors and diamide insecticides reveal the mechanisms of selectivity and resistance

  2024cites this paper
• Myopathic manifestations across the adult lifespan of patients with malignant hyperthermia susceptibility: a narrative review

  2024cites this paper
• Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor.

  2024cites this paper
• Development of Ryanodine Receptor (RyR) Inhibitors for Skeletal Muscle and Heart Diseases

  2023cites this paper
• A dual-targeted drug inhibits cardiac ryanodine receptor Ca2+ leak but activates SERCA2a Ca2+ uptake

  2023cites this paper
• 1,4-Benzothiazepines with Cyclopropanol Groups and Their Structural Analogues Exhibit Both RyR2-Stabilizing and SERCA2a-Stimulating Activities

  2023cites this paper
• A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment.

  2023cites this paper
• Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca2+ Monitoring

  2023cites this paper
• Characterization of Six Diamide Insecticides on Ryanodine Receptor: Resistance and Species Selectivity.

  2023cites this paper
• Drug development for the treatment of RyR1-related skeletal muscle diseases.

  2023cites this paper
• Three-dimensional perspective on ryanodine receptor mutations causing skeletal and cardiac muscle-related diseases.

  2022cites this paper
• [Therapeutic effects of novel type1 ryanodine receptor inhibitor on skeletal muscle diseases].

  2022cites this paper
• Synergistic FRET assays for drug discovery targeting RyR2 channels

  2022cites this paper
• Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2

  2022cites this paper
• Molecular basis for gating of cardiac ryanodine receptor explains the mechanisms for gain- and loss-of function mutations

  2022cites this paper
• Structural Insight Into Ryanodine Receptor Channelopathies

  2022cites this paper
• High-throughput platform for depolarization-induced Ca2+ release for skeletal muscle disease mutation validation and drug discovery

  2022cites this paper
• How Functional Genomics Can Keep Pace With VUS Identification

  2022cites this paper
• Development of a water-soluble ryanodine receptor 1 inhibitor.

  2022cites this paper
• A reconstituted depolarization-induced Ca2+ release platform for validation of skeletal muscle disease mutations and drug discovery

  2022cites this paper
• Reconstituting depolarization-induced calcium release

  2022cites this paper
• RYR-1-Related Diseases International Research Workshop: From Mechanisms to Treatments Pittsburgh, PA, U.S.A., 21-22 July 2022

  2022cites this paper
• Engineered Human Muscle Tissue from Multilayered Aligned Myofiber Sheets for Studies of Muscle Physiology and Predicting Drug Response

  2022cites this paper
• Therapies for RYR1-Related Myopathies: Where We Stand and the Perspectives.

  2021cites this paper
• Discovery of a novel family of FKBP12 "reshapers" and their use as calcium modulators in skeletal muscle under nitro-oxidative stress.

  2021cites this paper
• Enhanced CICR activity reduces ER Ca2+ level in cells expressing CPVT-linked mutant RyR2

  2021cites this paper
• A novel RyR1-selective inhibitor prevents and rescues sudden death in mouse models of malignant hyperthermia and heat stroke

  2021cites this paper
• The Medicinal Chemistry of Caffeine.

  2021cites this paper
• Differential effects of the formin inhibitor SMIFH2 on contractility and Ca2+ handling in frog and mouse cardiomyocytes

  2021cites this paper
• The reference genome and transcriptome of the limestone langur, Trachypithecus leucocephalus, reveal expansion of genes related to alkali tolerance

  2021cites this paper
• Optimizing Calcium Detection Methods in Animal Systems: A Sandbox for Synthetic Biology

  2021cites this paper
• Cardiac ryanodine receptor N-terminal region biosensors identify novel inhibitors via FRET-based high-throughput screening

  2021cites this paper
• Cardiac RyR N-terminal region biosensors for FRET-based high-throughput screening

  2021influential citation
• Regulatory mechanisms of ryanodine receptor/Ca2+ release channel revealed by recent advancements in structural studies

  2020cites this paper
• RyR1-targeted drug discovery pipeline integrating FRET-based high-throughput screening and human myofiber dynamic Ca2+ assays

  2020cites this paper
• Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline

  2020cites this paper
• Molecular basis for gating of cardiac ryanodine receptor: underlying mechanisms for gain- and loss-of function mutations

  2020cites this paper
• A novel RyR1 inhibitor prevents and rescues sudden death in a mouse model of malignant hyperthermia and heat stroke

  2020cites this paper
• Ryanodine receptor 1-related disorders: an historical perspective and proposal for a unified nomenclature

  2020cites this paper
• Structural basis for diamide modulation of ryanodine receptor

  2020cites this paper
• A novel saline-soluble, rapidly-metabolized RyR1 inhibitor rescues volatile anesthesia-induced death and environmental heat stroke in a mouse model relevant to malignant hyperthermia

  2020cites this paper
• [RyR2 mutation-linked arrhythmogenic diseases and its therapeutic strategies].

  2020cites this paper
• Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990–2019

  2020influential citation
• Discovery of potential species-specific green insecticides targeting lepidopteran ryanodine receptor.

  2020cites this paper
• Cellular high-throughput screening

  2020cites this paper
• Identification of drug modifiers for RYR1 related myopathy using a multi-species discovery pipeline

  2019cites this paper
• Structural development of a type-1 ryanodine receptor (RyR1) Ca2+-release channel inhibitor guided by endoplasmic reticulum Ca2+ assay.

  2019cites this paper
• High-throughput-compatible assays using a genetically-encoded calcium indicator

  2019cites this paper
• Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases

  2019influential citation
• Ryanodine Receptor 1-Related Myopathies: Diagnostic and Therapeutic Approaches

  2018cites this paper
• Screening for Novel Type 2 Ryanodine Receptor Inhibitors by Endoplasmic Reticulum Ca 2 1 Monitoring S

  year unknowninfluential citation